ORGENESIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.504 USD | +0.40% |
|
-1.58% | +0.66% |
| Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
| Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Orgenesis Inc.
bc6cdd849bc95646c15.8uBV-I9MdKMXroll7bwKR7wiBdnTU07yJTgncXn8cOw.o4Y6oOEBJuBf5uA8g-tsA4VwZIiWAn-KR34fNjfEM9nfjBaqxS8tlE7I7g~59d78e3a6f5a55d64a0b70f9dc81fb4b
Upcoming events on Orgenesis Inc.
Past events on Orgenesis Inc.
| 2024-04-15 05:07 pm | Q4 2023 Earnings Release |
| 2024-03-19 09:10 am | Bioprocessing Europe Summit |
| 2023-11-13 04:15 pm | Q3 2023 Earnings Release |
| 2023-08-11 08:00 am | Q2 2023 Earnings Call |
| 2023-08-11 07:00 am | Q2 2023 Earnings Release |
| 2023-06-08 10:00 am | Annual General Meeting - M&A Vote |
| 2023-05-22 | Benchmark Company Healthcare House Call Virtual Conference |
| 2023-05-10 04:30 pm | Q1 2023 Earnings Release |
| 2023-04-26 01:15 pm | INTERPHEX Conference |
| 2023-03-21 11:00 am | Q4 2022 Earnings Call |
| 2023-03-21 08:00 am | Q4 2022 Earnings Release |
| 2022-11-11 08:00 am | Q3 2022 Earnings Call |
| 2022-11-11 05:30 am | Q3 2022 Earnings Release |
| 2022-10-26 09:30 pm | TIL Therapies Summit |
| 2022-08-16 11:00 am | Interim 2022 Earnings Call |
| 2022-08-16 10:23 am | Interim 2022 Earnings Release |
| 2022-05-24 07:00 am | Q1 2022 Earnings Release |
| 2022-03-30 12:00 pm | FY 2021 Earnings Call |
| 2022-03-30 07:00 am | FY 2021 Earnings Release |
| 2021-12-16 09:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 33,3 33,5 -0.73% | 0,00 | 35,5 37,6 -5.58% | 36,0 30,7 17.35% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -24,6 -22,4 -9.84% | 0,00 | -16,8 -11,5 -46.09% | -7,54 -8,00 5.74% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,5 -22,3 -14.25% | 0,00 | -18,0 -11,5 -56.1% | -12,0 -9,20 -30% |
|
Net income Million USD | Released Forecast Spread | -24,1 -21,8 -10.65% | 1,11 | -18,1 -11,5 -56.98% | -14,9 -9,20 -61.84% |
|
EPS USD | Released Forecast Spread | -1,77 -1,37 -29.2% | 0,29 | -0,74 -0,47 -57.45% | -0,59 -0,37 -59.46% |
| Announcement Date | 09/03/20 | 09/03/21 | 30/03/22 | 22/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,89 9,00 -23.42% | 7,21 6,30 14.48% | 7,20 7,00 2.87% | 7,99 7,30 9.42% | 13,6 8,30 64.14% | 7,04 9,90 -28.85% | 6,98 10,7 -34.81% | 0,11 13,5 -99.19% |
|
EBIT Million USD | Released Forecast Spread | -6,91 -1,60 -331.63% | -3,24 -0,90 -259.56% | -4,73 -0,60 -688.67% | -0,01 -0,50 98.6% | 0,43 0,00 - | -3,21 1,30 -346.54% | -3,33 1,70 -295.82% | -2,24 2,60 -185.96% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,98 -1,60 -210.94% | -4,00 -0,90 -344% | -5,48 -0,60 -813.5% | -1,38 -0,50 -176.6% | -1,10 0,00 - | -4,13 1,30 -417.85% | -3,57 1,70 -310% | -12,3 2,60 -571.5% |
|
Net income Million USD | Released Forecast Spread | -5,02 -1,60 -213.5% | -4,01 -0,90 -345.44% | -5,43 -0,60 -804.5% | -1,36 -0,50 -171.2% | -4,10 0,00 - | -4,19 1,30 -422.23% | -4,13 1,70 -342.76% | -12,7 2,60 -586.65% |
|
EPS USD | Released Forecast Spread | -0,20 -0,06 -233.33% | -0,16 -0,04 -300% | -0,22 -0,02 -1000% | -0,05 -0,02 -150% | -0,16 0,00 - | -0,16 0,05 -420% | -0,15 0,06 -350% | -0,43 0,10 -530% |
| Announcement Date | 30/03/22 | 23/05/22 | 15/08/22 | 10/11/22 | 22/03/23 | 10/05/23 | 10/08/23 | 13/11/23 |
More events
Past sector events for Orgenesis Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORGS Stock
- Calendar Orgenesis Inc.
